Skip to content
Home/Companies/Healthcare/RS²D

RS²D

Healthcare·France·Exited·Held 10yr
Entry
2016
Hold
10yr
Exit
–

Who owns RS²D?

RS²D was owned by Capital Grand Est through Alsace Croissance (2011 vintage) since 2016, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Capital Grand Est
Investor
Capital Grand Est
Alsace Croissance · 2011 · Growth

Key facts

HQFrance
SectorHealthcare
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
–

More from Alsace Croissance

Other portfolio companies in the same fund.

EGH Industrie
Exited
IndustrialsFrance
Meazza Gide & De Angelis
Meazza Gide & De Angelis
Active
IndustrialsFrance· 2026
Estudia
Exited
EducationFrance· 2022
Liconograf
Liconograf
Exited
EducationFrance· 2018
Proximis
Exited 2021
TMTFrance· 2017
to
Fibermetrix
Fibermetrix
Active
TMTFrance· 2016

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Track RS²D

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy RS²D?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on RS²D.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue